Share on StockTwits

RBC Capital hoisted their price target on shares of CVS Caremark (NYSE:CVS) from $76.00 to $86.00 in a research note issued on Wednesday. The firm currently has an “outperform” rating on the stock. RBC Capital’s price objective suggests a potential upside of 11.64% from the stock’s previous close.

A number of other analysts have also recently weighed in on CVS. Analysts at Mizuho raised their price target on shares of CVS Caremark from $81.00 to $85.00 in a research note on Wednesday. They now have a “buy” rating on the stock. Separately, analysts at Cowen and Company raised their price target on shares of CVS Caremark from $80.00 to $85.00 in a research note on Wednesday. Finally, analysts at ISI Group raised their price target on shares of CVS Caremark from $86.00 to $88.00 in a research note on Tuesday. They now have a “strong-buy” rating on the stock. One investment analyst has rated the stock with a sell rating, three have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. CVS Caremark has a consensus rating of “Buy” and an average price target of $80.48.

CVS Caremark (NYSE:CVS) traded down 0.31% on Wednesday, hitting $77.03. 11,306,821 shares of the company’s stock traded hands. CVS Caremark has a 52-week low of $56.32 and a 52-week high of $79.43. The stock’s 50-day moving average is $76.92 and its 200-day moving average is $74.25. The company has a market cap of $90.356 billion and a price-to-earnings ratio of 19.68. CVS Caremark also saw some unusual options trading on Monday. Traders purchased 7,359 put options on the company. This represents an increase of approximately 776% compared to the typical volume of 840 put options.

CVS Caremark (NYSE:CVS) last released its earnings data on Tuesday, August 5th. The company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter in the previous year, the company posted $0.97 earnings per share. The company’s revenue for the quarter was up 10.7% on a year-over-year basis. Analysts expect that CVS Caremark will post $4.47 EPS for the current fiscal year.

CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.